Fetal growth restriction (FGR) is associated with placental

insufficiency and chronic hypoxia, which can increase oxidative stress and

inflammation in the developing brain. Melatonin has been proposed as a

neuroprotective intervention in this context. Researchers measure cerebral

oxidative stress markers, inflammatory cytokines, and neuronal injury in FGR

fetuses with and without melatonin treatment.